Nils Martin Krantz
Chief Executive Officer bei SMART EYE AB
Vermögen: 9 Mio $ am 31.03.2024
Profil
Nils Martin Krantz founded Smart Eye AB in 1999, where he is working as Chief Executive Officer from 1999.
Mr. Krantz also currently works at 1928diagnostics AB, as Director and Neoeye AB, as Director.
Mr. Krantz received his graduate degree from Chalmers University of Technology.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SMART EYE AB
3,11% | 30.06.2023 | 1 094 052 ( 3,11% ) | 9 Mio $ | 31.03.2024 |
Aktive Positionen von Nils Martin Krantz
| Unternehmen | Position | Beginn |
|---|---|---|
| SMART EYE AB | Chief Executive Officer | 01.01.1999 |
Neoeye AB
 Neoeye AB Electronic Equipment/InstrumentsElectronic Technology Neoeye AB develops and designs sensor solutions for HMI applications. The private company is based in Stockholm, Sweden. | Director/Board Member | - |
1928diagnostics AB
 1928diagnostics AB Medical SpecialtiesHealth Technology 1928diagnostics AB develops diagnostic software solutions for bacterial infections. It delivers extended resistance profiles and bacterial identification. The firm replaced traditional bacterial culturing methods and develops a personalized medicine addressing to antibiotic resistance. The company was founded by Susanne Staaf and Kristina Lagerstedt in 2014 and is headquartered in Gothenburg, Sweden. | Director/Board Member | - |
Ausbildung von Nils Martin Krantz
| Chalmers University of Technology | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SMART EYE AB | Health Technology |
| Private Unternehmen | 2 |
|---|---|
1928diagnostics AB
1928diagnostics AB Medical SpecialtiesHealth Technology 1928diagnostics AB develops diagnostic software solutions for bacterial infections. It delivers extended resistance profiles and bacterial identification. The firm replaced traditional bacterial culturing methods and develops a personalized medicine addressing to antibiotic resistance. The company was founded by Susanne Staaf and Kristina Lagerstedt in 2014 and is headquartered in Gothenburg, Sweden. | Health Technology |
Neoeye AB
Neoeye AB Electronic Equipment/InstrumentsElectronic Technology Neoeye AB develops and designs sensor solutions for HMI applications. The private company is based in Stockholm, Sweden. | Electronic Technology |
